Search clinical trials for: cemiplimab REGN2810
Total 146 results
-
M.D. Anderson Cancer CenterNot yet recruitingMetastatic Colorectal Cancer | KRAS G12C MutationsUnited States
-
SillaJen, Inc.Regeneron PharmaceuticalsActive, not recruitingRenal Cell CarcinomaUnited States, Australia, Korea, Republic of
-
Sidney Kimmel Cancer Center at Thomas Jefferson...Regeneron Pharmaceuticals; Prostate Cancer FoundationWithdrawnStage III Prostate Cancer | Stage IV Prostate Cancer | Stage IVA Prostate Cancer | Stage IVB Prostate Cancer | Stage IIIA Prostate Cancer | Stage IIIB Prostate Cancer | Stage IIIC Prostate Cancer
-
OncoNano Medicine, Inc.RecruitingLymphoma, Non-Hodgkin | Follicular Lymphoma | Carcinoma in Situ | Mantle Cell Lymphoma | Metastatic Cancer | Bladder Cancer | Skin Cancer | Triple Negative Breast Cancer | Cervix Cancer | Diffuse Large B Cell Lymphoma | Head and Neck Squamous Cell Carcinoma | Tumor, Solid | Tumor Recurrence | Uveal Melanoma, RecurrentUnited States
-
Immune-Onc TherapeuticsRegeneron PharmaceuticalsActive, not recruiting
-
Duke UniversityRegeneron PharmaceuticalsRecruitingNon-small Cell Lung Cancer (NSCLC)United States
-
HotSpot Therapeutics, IncRecruitingSolid Tumor, Adult | Relapsed Cancer | Refractory CancerUnited States
-
SanofiActive, not recruitingMalignant Melanoma | Squamous Cell Carcinoma of SkinGermany, Spain, France, Chile, United States, Australia, Italy
-
Regeneron PharmaceuticalsSanofiCompletedAdvanced Cancer | Advanced MalignanciesUnited States, Spain, Australia
-
Replimune Inc.Regeneron PharmaceuticalsActive, not recruitingCutaneous Squamous Cell Carcinoma | Advanced Cutaneous Squamous Cell Carcinoma | Metastatic Cutaneous Squamous Cell CarcinomaSpain, United States, France, Australia, Germany, Canada, Greece, Bulgaria, Italy, Poland
-
Maia BiotechnologyRecruitingCarcinoma, Non-Small-Cell LungPoland, Australia, Bulgaria, Hungary
-
The Netherlands Cancer InstituteGenzyme, a Sanofi CompanyRecruitingCarcinoma, Non-Small-Cell LungNetherlands
-
Vyriad, Inc.Regeneron PharmaceuticalsRecruitingMelanoma | Head and Neck Squamous Cell Carcinoma | Colo-rectal CancerUnited States, Brazil
-
Servier Bio-Innovation LLCRegeneron Pharmaceuticals; Institut de Recherches Internationales ServierNot yet recruitingNon-small Cell Lung Cancer (NSCLC)Hong Kong, United States, Australia
-
Jason J. Luke, MDRecruitingMelanoma | Cervical Cancer | Hepatocellular Carcinoma | Gastric Cancer | Colorectal Cancer | NSCLC | Advanced Solid Tumors | Cholangiocarcinoma | Bladder Cancer | Renal Cancer | Anal Cancer | Merkel Cell Carcinoma | HNSCCUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron PharmaceuticalsActive, not recruitingHormone Receptor-positive Breast CancerUnited States
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)RecruitingStage III Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Stage IV Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8 | Advanced Dedifferentiated Liposarcoma | Metastatic Dedifferentiated Liposarcoma | Locally Advanced Dedifferentiated Liposarcoma | Unresectable Dedifferentiated...United States
-
Regeneron PharmaceuticalsCompletedDiabetic Macular Edema | Neovascular Age-Related Macular DegenerationUnited States
-
Krzysztof MisiukiewiczRegeneron PharmaceuticalsRecruitingLocally Advanced Head and Neck Squamous Cell CarcinomaUnited States
-
Johns Hopkins UniversityCompletedCutaneous Toxicity From ICI TherapyUnited States
-
OncoResponse, Inc.RecruitingMelanoma | Cancer | Non Small Cell Lung Cancer | Metastatic Cancer | Advanced Solid Tumor | Leiomyosarcoma | Head and Neck Squamous Cell Carcinoma | Liposarcoma | Malignant Neoplasm | Tumor, SolidUnited States
-
Mayo ClinicNational Cancer Institute (NCI)RecruitingPreviously Treated Myelodysplastic Syndrome | Recurrent Adult Acute Myeloid Leukemia | Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | B-Cell Non-Hodgkin Lymphoma | Refractory T-Cell Non-Hodgkin Lymphoma | Refractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Recurrent T-Cell... and other conditionsUnited States
-
SanofiRecruitingPlasma Cell MyelomaCzechia, Australia, Chile, France, Spain, United States, Brazil, China, Greece, Japan, Korea, Republic of, Sweden, Taiwan, Finland, Italy, Russian Federation
-
Institute of Liver and Biliary Sciences, IndiaNot yet recruiting
-
Sidney Kimmel Comprehensive Cancer Center at Johns...National Cancer Institute (NCI); Genzyme, a Sanofi Company; American Association...CompletedMetastatic Pancreatic CancerUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRegeneron Pharmaceuticals; Genzyme, a Sanofi CompanyRecruitingMetastatic Uveal MelanomaUnited States
-
H. Lee Moffitt Cancer Center and Research InstituteRecruitingMerkel Cell Carcinoma | Cutaneous Melanoma | Cutaneous Squamous Cell CarcinomaUnited States
-
BioNTech SERecruitingNon-Small Cell Lung CancerSpain, Germany, Turkey, United States, Hungary, United Kingdom, Poland
-
GlaxoSmithKlineCompletedSkin Infections, BacterialNetherlands, Costa Rica, Germany, Mexico, Canada, India, Poland, South Africa, France, Peru
-
Inimmune CorporationAvance Clinical Pty Ltd.Not yet recruiting
-
Memorial Sloan Kettering Cancer CenterRegeneron PharmaceuticalsRecruitingHead and Neck Cancer | Head and Neck Squamous Cell Carcinoma | HNSCC | Head Cancer | Neck Cancer | Head Cancer NeckUnited States
-
Duke UniversityRegeneron PharmaceuticalsNot yet recruitingNon Small Cell Lung Cancer
-
Wyeth is now a wholly owned subsidiary of PfizerCompleted
-
Jules Bordet InstituteRecruitingMelanoma | Renal Cell Carcinoma | Breast Cancer | Head and Neck Cancer | Small Cell Lung Cancer | Hepatocellular Carcinoma | Non Small Cell Lung Cancer | Mesothelioma, Malignant | Bladder Cancer | Gastrointestinal Cancer | Merkel Cell Carcinoma | Non-melanoma Skin Cancer | MSI-H Colorectal CancerBelgium
-
Maastricht University Medical CenterErasmus Medical Center; Jules Bordet Institute; Academisch Ziekenhuis MaastrichtRecruitingUnspecified Adult Solid Tumor, Protocol SpecificNetherlands, Belgium
-
University of Wisconsin, MadisonBristol-Myers Squibb; National Cancer Institute (NCI); United States Department... and other collaboratorsRecruiting
-
Oncovir, Inc.National Cancer Institute (NCI); University of Missouri-Columbia; Icahn School... and other collaboratorsCompletedMelanoma | Sarcoma | Head and Neck Cancer | Non-Melanoma Skin CancersUnited States
-
Regeneron PharmaceuticalsCompletedNeovascular Age-Related Macular DegenerationUnited States
-
Regeneron PharmaceuticalsBayerCompleted
-
Regeneron PharmaceuticalsSanofiCompletedSolid TumorsUnited States, Canada
-
Dana-Farber Cancer InstituteRegeneron PharmaceuticalsActive, not recruitingAdvanced Cancer | Cutaneous Squamous Cell CarcinomaUnited States
-
Regeneron PharmaceuticalsRecruitingMultiple MyelomaUnited States, Spain, France, Greece
-
QuantumLeap Healthcare CollaborativeRecruitingBreast Cancer | Breast Neoplasms | Breast Tumors | HER2-positive Breast Cancer | Angiosarcoma | Locally Advanced Breast Cancer | HER2-negative Breast Cancer | TNBC - Triple-Negative Breast Cancer | Hormone Receptor Positive Tumor | Hormone Receptor Negative Tumor | Early-stage Breast CancerUnited States
-
Medical College of WisconsinRecruitingInvasive Breast CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Varian Medical SystemsSuspendedLung Non-Small Cell Carcinoma | Stage IV Lung Cancer AJCC v8 | Stage III Lung CancerUnited States